A nurse is caring for a client who has asthma. The client asks the nurse how albuterol helps his breathing. Which of the following information should the nurse include in the response? (Select all that apply.)
The medication will relieve wheezing.
The medication will reduce inflammation.
The medication will increase the amount of mucus.
The medication will decrease coughing episodes.
The medication will open the airways.
Correct Answer : A,E
A. The medication will relieve wheezing: Albuterol is a short-acting beta agonist bronchodilator that works by quickly relaxing the smooth muscles of the airways, leading to rapid bronchodilation. This helps relieve symptoms such as wheezing, shortness of breath, and chest tightness commonly associated with asthma exacerbations.
B. The medication will reduce inflammation: Albuterol is not primarily indicated for reducing inflammation in asthma. While it can help alleviate symptoms of bronchospasm, it does not target the underlying inflammation associated with asthma.
C. The medication will increase the amount of mucus: Albuterol does not increase mucus production. In fact, it is a bronchodilator medication that primarily targets airway smooth muscle relaxation and bronchodilation to improve airflow and relieve symptoms.
D. The medication will decrease coughing episodes: Albuterol can help decrease coughing episodes by relieving bronchospasm and improving airflow. However, its primary mechanism of action is bronchodilation rather than directly targeting coughing.
E. The medication will open the airways: Albuterol works by stimulating beta-2 adrenergic receptors in the airway smooth muscles, resulting in relaxation of these muscles and dilation of the bronchial tubes. This action helps to open the airways, allowing for improved airflow and easier breathing.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A) Theophylline:
Theophylline is a bronchodilator medication that is used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). It has a slower onset of action compared to short-acting beta-agonists like albuterol and is not typically used as the initial treatment for acute asthma exacerbations.
B) Montelukast:
Montelukast is a leukotriene receptor antagonist used for the long-term control and prevention of asthma symptoms, but it is not typically used as the initial treatment for acute asthma exacerbations. Its onset of action is slower compared to short-acting beta-agonists like albuterol.
C) Albuterol.
Albuterol is a short-acting beta agonist bronchodilator commonly used as a first-line treatment for acute asthma exacerbations. It works by quickly relaxing the smooth muscles of the airways, leading to rapid bronchodilation and improvement of airflow. This can help alleviate the patient's symptoms of shortness of breath and wheezing.
D) Salmeterol:
Salmeterol is a long-acting beta-agonist bronchodilator used for the maintenance treatment of asthma and COPD, but it is not typically used as the initial treatment for acute asthma exacerbations. Its onset of action is slower compared to short-acting beta-agonists like albuterol, and it is not recommended for rapid relief of acute symptoms.
Correct Answer is B
Explanation
A) Antihistamines:
Antihistamines are commonly used in the treatment of allergic reactions, including anaphylaxis. They work by blocking the effects of histamine, which is released during an allergic reaction, and can help alleviate symptoms such as itching, hives, and nasal congestion. Antihistamines are typically included in the treatment regimen for anaphylaxis but should not be relied upon as the sole treatment.
B) Vasodilators.
Vasodilators are medications that widen blood vessels, leading to a decrease in blood pressure. In the context of anaphylaxis, where blood pressure can drop precipitously due to systemic vasodilation, the use of vasodilators can exacerbate hypotension, potentially worsening the patient's condition. Therefore, vasodilators should be avoided in the management of anaphylaxis.
C) Corticosteroids:
Corticosteroids, such as prednisone or methylprednisolone, are used in the management of anaphylaxis to reduce inflammation and prevent late-phase allergic reactions. They are not typically used as first-line treatment during the acute phase of anaphylaxis but may be administered after initial stabilization to prevent recurrence of symptoms.
D) Bronchodilators:
Bronchodilators, such as albuterol, are used to relieve bronchospasm and improve airflow in conditions such as asthma and chronic obstructive pulmonary disease (COPD). While bronchospasm can occur during anaphylaxis, bronchodilators may still be used to address this symptom. However, they should be used cautiously, and their administration should not delay the administration of epinephrine, which is the primary treatment for anaphylaxis.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
